# M. H. Carnegie & Co.

> M. H. Carnegie & Co. is a VC fund backing Health Care and Medical Device. See 13 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Paddington, Australia
- Total investments: 13
- Last investment: Mar 2025
- Lead investor: 23%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company-beta/3594932/
- X (Twitter): https://twitter.com/mhcarnegie
- Website: http://mhcarnegie.com

M. H. Carnegie & Co. is a VC fund in Paddington focused on Health Care and Medical Device. M.H. Carnegie & Co. was launched by Mark Carnegie in 2010 with total equity commitments of $132 million to capitalise on the post financial crisis environment in the Australian market for smaller alternative investment opportunities. M.H. Carnegie & Co. was launched with a focus and expertise in expansion capital, as well as operating realestate.

## Contacts

5 contacts available for M. H. Carnegie & Co.. Shizune tracks 4 team members at M. H. Carnegie & Co.. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/m-h-carnegie-co?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $7M–$7M |
| Series A | $15M–$20M |
| Series B | $21M–$39M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 23% |
| Medical Device | 3 | 23% |
| Medical | 2 | 15% |
| eSports | 1 | 8% |
| Blockchain | 1 | 8% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 15% |
| Seed | 1 | 8% |
| Series A | 1 | 8% |
| Series C | 1 | 8% |
| Series D | 1 | 8% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 3 | 23% |
| Panama | 1 | 8% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Mark Carnegie | Founder | 6 | https://shizune.co/investors/profile/mark-carnegie |
| Kate Thompson | Partner | 0 | https://shizune.co/investors/profile/kate-thompson-2 |
| Matthew Beach | Partner | 0 | https://shizune.co/investors/profile/matthew-beach |
| Trevor Moody | Managing Director | 2 | https://shizune.co/investors/profile/trevor-moody-2 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cardiac Dimensions | Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation. | $53M | Series E | Mar 20, 2025 |  |
| Cardiac Dimensions | Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation. | $35M | Series D | Jan 05, 2023 |  |
| Ignite Tournaments | esports, mobile games, streaming, crypto, blockchain, and tournament organization | $7M |  | Mar 03, 2022 |  |
| Ignite Tournaments | esports, mobile games, streaming, crypto, blockchain, and tournament organization | $7M | Seed | Mar 03, 2022 |  |
| Ignite Tournaments | esports, mobile games, streaming, crypto, blockchain, and tournament organization | $7M | Seed | Mar 03, 2022 |  |
| Cardiac Dimensions | Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation. | $17.5M | Series C | Sep 29, 2020 |  |
| EBR Systems | EBR Systems, Inc. is an early-stage development venture pursuing novel approaches in cardiac rhythm management. EBR Systems develops devices for the treatment of cardiac arrhythmias. | $30M | Private Equity | Aug 27, 2019 |  |
| Cardiac Dimensions | Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation. | $39M | Series B | Apr 26, 2018 |  |
| Simplify Medical | Simplify Medical designs, develops, and manufactures cervical artificial discs for use in the spine. It offers an MRI compatible motion preserving artificial cervical disc that is used to treat single level symptomatic cervical disc disease.The company provides its products for skeletally mature patients for reconstruction of the disc at onelevel from C3-C7 following single-level discectomy for intractable radiculopathy, such as arm pain or a neurological deficit.Simplify Medical was founded in 2015 and is based in Mountain View, California. | $23M | Series B | Feb 09, 2018 |  |
| EBR Systems | EBR Systems, Inc. is an early-stage development venture pursuing novel approaches in cardiac rhythm management. EBR Systems develops devices for the treatment of cardiac arrhythmias. | $50M | Private Equity | Nov 14, 2017 |  |

10 of 13 investments shown.

## Co-investors
- [Lumira Ventures](https://shizune.co/investors/profile/lumira-ventures) — VC Fund, 6 deals together
- [Arboretum Ventures](https://shizune.co/investors/profile/arboretum-ventures) — VC Fund, 4 deals together
- [Hostplus](https://shizune.co/investors/profile/hostplus) — VC Fund, 4 deals together
- [EQT Life Sciences](https://shizune.co/investors/profile/life-sciences-partners) — VC Fund, 4 deals together
- [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund, 3 deals together
- [Aperture Venture Partners](https://shizune.co/investors/profile/aperture-venture-partners) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Coinbase Ventures](https://shizune.co/investors/profile/coinbase-ventures) — VC Fund
- [Polychain](https://shizune.co/investors/profile/polychain-capital) — VC Fund
- [Digital Currency Group](https://shizune.co/investors/profile/digital-currency-group) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Morningstar Ventures](https://shizune.co/investors/profile/morningstar-ventures) — VC Fund
- [AU21 Capital](https://shizune.co/investors/profile/au21-capital) — VC Fund
- [Avalon Wealth Club](https://shizune.co/investors/profile/avalon-wealth-club) — VC Fund

## Featured in investor lists
- [All Investors in Panama](https://shizune.co/investors/investors-panama)
- [All VC Funds in Panama](https://shizune.co/investors/vc-funds-panama)
- [Financial Services VC Funds in Panama](https://shizune.co/investors/financial-services-vc-funds-panama)
- [Cryptocurrency VC Funds in LATAM](https://shizune.co/investors/cryptocurrency-vc-funds-latam)
- [Cryptocurrency Investors in Panama](https://shizune.co/investors/cryptocurrency-investors-panama)
- [Cryptocurrency VC Funds in Panama](https://shizune.co/investors/cryptocurrency-vc-funds-panama)

## FAQ

### What does M. H. Carnegie & Co. invest in?

M. H. Carnegie & Co. invests primarily in Health Care, Medical Device and Medical startups, most often at Series B and Seed stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is M. H. Carnegie & Co.'s check size?

M. H. Carnegie & Co. typically joins rounds of $7M–$7M at Seed, $15M–$20M at Series A and $21M–$39M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds M. H. Carnegie & Co. participates in.

### How do I contact M. H. Carnegie & Co.?

Public channels for M. H. Carnegie & Co. include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at M. H. Carnegie & Co.?

The team at M. H. Carnegie & Co. includes Mark Carnegie (Founder), Kate Thompson (Partner) and Matthew Beach (Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co